In a randomized controlled trial of albumin plus terlipressin or placebo for the treatment of HRS-AKI [14], AKI was reversible without renal replacement therapy after 14 and 30 days in 17–18% of 101 patients receiving placebo, due to unstated reasons, compared to 32% of 199 patients treated with terlipressin. Here, ALB is linked to acute kidney injury.